A novel hypothesis: regulatory B lymphocytes shape outcome from experimental stroke

Area of Science:

• Neuroscience
• Immunology
• Stroke Research

Background:

• Inflammatory immune cells contribute to middle cerebral artery occlusion (MCAO) stroke.
• Previous immunotherapies targeting neutrophils have failed in clinical trials.
• Regulatory T- and B-cells may offer neuroprotection by suppressing inflammation.

Purpose of the Study:

• To investigate the role of regulatory B-cells in MCAO-induced brain injury.
• To determine if regulatory B-cells can limit central nervous system damage.
• To explore potential novel immunotherapies for stroke.

Main Methods:

• Comparison of MCAO outcomes in B-cell deficient mice versus wild-type mice.
• Transfer of wild-type (WT) and IL-10-deficient B-cells into B-cell deficient mice.
• Assessment of infarct volume, mortality, functional deficits, and immune cell infiltration.

Main Results:

• B-cell deficient mice exhibited larger infarct volumes, increased mortality, and worse functional deficits post-MCAO.
• MCAO induced higher numbers of activated T-cells, macrophages, microglia, and neutrophils in B-cell deficient mice.
• Transfer of WT B-cells, but not IL-10-deficient B-cells, prevented MCAO-induced pathology.

Conclusions:

• IL-10-secreting B-cells are critical for limiting brain damage in stroke.
• Regulatory B-cells represent a novel therapeutic target for stroke.
• Enhancing regulatory B-cell function may be a promising strategy for stroke treatment.